#HVO hVIVO PLC – Plans for a new larger state-of-the-art facility August 29, 2023 – Posted in: Blog, hVIVO (HVO)

·    Capacity increase to 50 quarantine beds with optionality to expand to 70 ·    Expansion of laboratory services to include cutting edge labs ·    Largely funded by multiple hVIVO clients hVIVO plc (AIM & Euronext: HVO), the world leader in testing infectious and respiratory disease products using human challenge clinical trials, announces its plans for a new consolidated facility at the fast-growing life sciences hub in Canary Wharf, London. The expansion, largely funded by hVIVO…

Continue reading